Denali Therapeutics Inc (DNLI) COM USD0.01

Sell:$20.58Buy:$20.63Price increased$0.45 (2.23%)

NASDAQ:Price increased0.95%
Market closed |
Prices delayed by at least 15 minutes
Sell:$20.58
Buy:$20.63
Change:Price increased$0.45 (2.23%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:$20.58
Buy:$20.63
Change:Price increased$0.45 (2.23%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$20.24
Previous close$20.16
Market cap$3.08bn
P/E ratio-99999.99
Volume83,042
Dividend yield0.00%
EMS-

Company information

Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for the treatment of ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue158.59m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.